Why the study?
Does intravenous ipratropium bromide increase heart rate and duration of action compared to atropine sulfate in patients?
Does intravenous ipratropium bromide increase heart rate and duration of action compared to atropine sulfate in patients?
Intravenous ipratropium bromide produces a more prolonged vagolytic effect on heart rate compared to atropine, suggesting potential utility for vagally mediated conduction disturbances.
No takes yet. Share an insight, caveat, or question.
Ipratropium may extend vagolytic coverage in bradycardia; hypothesis-generating for conduction disturbances, pending randomized confirmation.
Libersa et al. (1988) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: